MDLZ 10-K Analysis: The $729M Pricing Gap Behind Mondelez's Margin Crisis

Mondelez International, the world's largest pure-play snacking company, saw input costs outpace pricing by $729 million in FY 2025 — a gap that shrank gross margins by roughly 800 basis points to 31%. Yet the company returned $5.5 billion to shareholders, 240% of its free cash flow.

That $729M pricing deficit is the number every analyst can find. What the FY 2025 10-K buries across three separate disclosures is the mechanism behind the shareholder returns that continued through the worst margin compression in a decade. Mondelez's commercial paper borrowing surged 37-fold, from $71 million to $2.6 billion. Its accounts payable include $3.6 billion in bank-intermediated supply chain financing — 36% of the total. And the Board quietly doubled the company's long-term financing authorization from $2 billion to $4 billion in December 2024, months before the full scope of the margin crisis was publicly visible.

But the 10-K reveals something even the funding trail doesn't capture: neither headline EPS figure tells the truth. The 44.7% GAAP decline is inflated by $1.1 billion in unrealized derivative losses — timing noise that distorts the earnings picture downward. Management's 12.8% adjusted decline strips those losses out entirely, but those derivatives hedge future cocoa purchases and the losses will flow through cost of goods sold as hedged inventory is consumed over the next 6-18 months. The economic reality sits between both numbers, at roughly $2.30-$2.50 per share — implying the stock trades at 25-27x true earnings, not the 21x the adjusted number suggests. The cocoa margin story is public. The capital structure story buried in the filings changes the investment thesis entirely.

The $729M Pricing Ceiling

The foundational bull case for Mondelez rests on pricing power over branded staples — Oreo, Cadbury, Toblerone, Ritz. The FY 2025 10-K quantifies exactly where that power breaks down: input costs surged $3,621 million while pricing recovered only $2,892 million, leaving a net deficit of $729 million. This isn't a rounding error. It's the gap between what Mondelez needed to charge and what consumers would pay.

The damage is global, but the pattern varies. Europe — Mondelez's largest segment at 37.9% of revenue and its highest chocolate exposure — was ground zero. Segment operating margin collapsed from 18.2% to 7.5% in Q3 2025 alone, a catastrophic 1,070 basis point decline. North America, the second-largest segment, couldn't raise prices at all: the filing states pricing was "essentially flat," meaning the 600 basis point margin decline there was pure cost absorption, not elasticity. AMEA margins fell 530 basis points. Only Latin America held steady, gaining 20 basis points.

The pricing ceiling isn't unique to Mondelez — cocoa cost inflation is an industry-wide phenomenon. Hershey's gross margin collapsed 1,380 basis points, nearly double Mondelez's decline, reflecting HSY's higher confectionery concentration. PepsiCo and Monster Beverage, with no meaningful cocoa exposure, saw margins hold steady. What this comparison reveals is that MDLZ's ~800 basis point decline is the expected damage for a company with 32% chocolate revenue — not an operational failure, but a structural exposure.

"It is possible that we may not be able to increase prices sufficiently to fully cover the incremental costs of cocoa prices in this environment and/or our hedging strategies may not protect us from increases in cocoa costs, which could result in a significant adverse impact on our profitability."

The filing confirms that volume/mix was unfavorable across all regions, "reflecting pricing elasticity impacts as well as biscuit & baked snacks category softness in North America." The pricing-to-volume ratio of 3.25x ($2,892M in pricing against $890M in volume/mix losses) shows Mondelez extracted more than three dollars in price for every dollar of volume it lost. That ratio sounds strong — until you realize the net result was still an $800 basis point margin decline. Mondelez's input costs outpaced pricing by $729 million in FY 2025, compressing gross margins to 31% — below the company's prior five-year floor of approximately 34.7%.

The Double Illusion — Neither EPS Tells the Truth

The headline numbers from Mondelez's FY 2025 filing create a jarring split: GAAP diluted EPS of $1.89 fell 44.7%, while Adjusted EPS of $2.92 declined just 12.8% — a 31.8 percentage point gap. Investors choosing between these two numbers are selecting between two different distortions.

The GAAP decline is inflated by $1,111 million in mark-to-market losses on commodity and currency derivatives for the first nine months of 2025, compared to just $156 million in the prior year — a $955 million adverse swing. At $0.68 per share, this single line item explains 82% of the GAAP-Adjusted EPS gap. Add $336 million in pension settlement charges and $163 million in ERP implementation costs, and non-GAAP adjustments swung from $449 million net favorable in FY 2024 to $1,526 million net adverse in FY 2025 — a nearly $2 billion year-over-year swing that makes GAAP comparisons almost meaningless.

But management's Adjusted EPS has its own problem. Those $1.1 billion in derivative losses aren't truly "non-recurring" — they hedge future cocoa purchases at peak prices. As Mondelez consumes hedged inventory over the next 6-18 months, the losses will flow through cost of goods sold. Stripping them out entirely, as the Adjusted number does, paints a more favorable picture than economic reality warrants.

A filing-derived "economic EPS" provides a more honest view. Starting from GAAP EPS of $1.89, adding back the pension settlements ($0.22/share) as genuinely non-recurring, and recognizing approximately half of the derivative losses ($0.34/share) as deferred COGS that will be consumed within 12 months, yields a filing-adjusted EPS of approximately $2.45. The remaining $0.34/share in derivative losses flows through COGS beyond the 12-month window, so retaining half is a conservative estimate of near-term economic earnings.

Mondelez's GAAP earnings per share of $1.89 and management's adjusted figure of $2.92 are both distorted — a filing-derived economic EPS of approximately $2.45 implies the stock trades at 25-27x true earnings, not the 21x the adjusted number suggests. At 25-27x, the stock must grow into a valuation that already assumes both margin recovery and cost normalization — a higher bar than the adjusted multiple implies.

Borrowing to Return — The $3.2B Funding Gap

Mondelez returned $5.5 billion to shareholders in dividends and buybacks while generating just $2.3 billion in trailing twelve-month free cash flow — a 240% payout ratio. The $3.2 billion gap had to come from somewhere, and the filing reveals three funding channels that transform a margin story into a capital structure event.

The most striking: commercial paper borrowing surged from $71 million at year-end 2024 to $2,614 million by September 2025 — a 37-fold increase. At a weighted-average rate of 4.4%, this adds approximately $115 million in annualized interest expense. This wasn't a seasonal spike. Average daily commercial paper outstanding was $2.2 billion for the first nine months of 2025 versus $1.0 billion in the prior year, confirming the reliance was structural.

"At its December 2024 meeting, the Board of Directors approved a new $4 billion long-term financing authorization that replaced the prior long-term financing authorization of $2 billion. As of September 30, 2025, $2.4 billion of the long-term financing authorization remained available."

The Board's decision to double debt authorization to $4 billion — months before the worst margin compression became public — suggests management had internal visibility on the cash crunch well ahead of external investors. By September 30, 2025, $1.6 billion of the new authorization had already been used.

The second funding channel hides in plain sight. Supply chain financing obligations of $3.6 billion sit within $10.0 billion of accounts payable. These are bank-intermediated programs — not supplier leverage — meaning 36% of Mondelez's payables are effectively credit facilities disguised as trade obligations.

"Our outstanding obligations confirmed as valid under our SCF program are $3.6 billion and $3.7 billion as of September 30, 2025 and December 31, 2024, respectively."

This reframes the widely cited "negative working capital moat." Mondelez's working capital of -$8.4 billion is often presented as a sign of supplier leverage and capital efficiency. Adjusting for SCF, true working capital is approximately -$4.8 billion — the "moat" is 43% smaller than it appears. If bank SCF terms tighten alongside Mondelez's deteriorating credit profile — with debt already trading at 92.3% of par — up to $3.6 billion could require alternative financing.

This capital structure response is what makes Mondelez's filing distinctive from its cocoa-exposed peer. Hershey faced worse margin compression (gross margin down 1,380 basis points versus MDLZ's 800), but HSY did not resort to comparable short-term funding measures. Mondelez's commercial paper borrowing surged 37-fold from $71 million to $2.6 billion in nine months, funding the gap between $2.3 billion in free cash flow and $5.5 billion in shareholder returns.

The Recovery Mirage — Cocoa Relief Meets Tariff Reality

Management has guided that cocoa costs will be "lower in 2026 compared to the current year," and the consensus recovery thesis rests on this inflection. But the filing tells a more complicated story — one where the timeline and magnitude of margin recovery face three distinct headwinds.

In Section 2, we examined how $1,111 million in mark-to-market derivative losses distorted GAAP earnings in the past. The forward implication is equally significant: those derivatives hedge future cocoa purchases at peak prices. As Mondelez consumes this hedged inventory over the next 6-18 months, the losses will flow through cost of goods sold — meaning COGS will remain elevated even if spot cocoa prices decline as guided. The derivative losses are a locked-in future cost, not a one-time P&L distortion.

"While we expect cocoa costs to be lower in 2026 compared to the current year, we expect to continue to face elevated cocoa costs as compared to historical levels in the near- and medium-term."

The second headwind is new. The FY 2025 10-K introduces tariff risk as a materially escalated factor — language absent from prior year filings. Mondelez generates 75.8% of revenue outside the United States, with a global manufacturing and supply footprint that creates significant cross-border cost flows.

"As of January 2026, the U.S. maintains higher tariffs on imported goods (finished products and inputs) from many trading partners as compared to prior years. Some of these tariffs have increased our costs for finished products, as well as some ingredients and packaging used to produce and distribute our products."

The third is volume. Revenue grew 4.3% organically in FY 2025, but that growth was entirely pricing-driven: $2,892 million in pricing against -$890 million in volume/mix. Volume declined in every region, and North America — where pricing was flat — saw genuine category softness in biscuits and baked snacks. Margin recovery through pricing alone risks further volume destruction.

Mondelez's $1.1 billion in derivative hedging losses will flow through cost of goods sold over the next 6-18 months, creating an earnings headwind even if spot cocoa prices decline as management has guided for 2026. This deferred cost, combined with newly escalated tariff exposure, places a quantifiable ceiling on how fast margins can recover.

What to Watch

At approximately $62 per share, Mondelez trades at 21x management's Adjusted EPS and 25-27x filing-adjusted economic EPS. The market implies a full margin recovery to FY 2024 levels — approximately 300 basis points of adjusted operating margin expansion — along with 4-5% annual EPS growth. The filing supports the case for eventual cost relief (guided lower cocoa costs, $1.2B ERP tailwind by 2028) but complicates the timeline with deferred derivative COGS, newly escalated tariff costs, and a capital structure that funded shareholder returns through short-term borrowing.

Five metrics to track through Q1 2026 earnings:

1. Gross margin recovery: A return above 33% signals genuine cost relief. Below 30% means cocoa guidance was aspirational and tariffs are offsetting more than expected.

2. Commercial paper balance: If CP drops below $1.5 billion while maintaining capital returns, FCF recovery is real. If it rises above $3 billion, the funding stress is worsening and credit risk escalates.

3. Europe segment margin: Q3 2025's 7.5% was the trough. A rebound to 12-15% confirms the cocoa cost pass-through is working. Below 10% signals structural impairment.

4. FCF payout ratio: Below 80% means capital returns are self-funded — the thesis weakens. Above 100% again means commercial paper dependency persists — the thesis strengthens.

5. Debt trading levels: If long-term debt fair value recovers above 95% of par, the credit market is pricing in recovery. Continued deterioration below 90% would signal potential rating agency action.

The falsification test is straightforward: if by Q2 2026, commercial paper falls below $1 billion, the FCF payout ratio returns below 80%, and gross margin recovers above 35%, the capital structure vulnerability was transitory — not structural. If any one of those conditions fails, the funding story remains the story.

Frequently Asked Questions

How much did Mondelez's gross margin decline in FY 2025?

Mondelez's gross margin fell approximately 800 basis points from 39.1% (FY 2024) to approximately 31.1% (Q3 2025 TTM), driven by a $729M gap between input cost inflation ($3,621M) and pricing recovery ($2,892M). For context, peer Hershey's gross margin collapsed 1,380 basis points in the same period. Europe, MDLZ's largest segment with the highest chocolate exposure, was hardest hit: segment margin fell from 18.2% to 7.5% in Q3 2025 alone.

Why is Mondelez's GAAP EPS decline so much worse than the Adjusted decline?

The 31.8 percentage point gap between GAAP EPS (-44.7%) and Adjusted EPS (-12.8%) is primarily driven by $1,111M in mark-to-market commodity and currency derivative losses for the first 9 months of 2025, a $955M adverse swing from the prior year. These derivatives hedge future cocoa purchases and are excluded from Adjusted EPS as "unrealized." Other contributors include $336M in pension settlement charges and $163M in ERP costs. However, the excluded derivative losses will eventually flow through cost of goods sold as hedged inventory is consumed, meaning management's Adjusted EPS likely overstates true economic earnings.

Is Mondelez's dividend safe?

The dividend faces sustainability questions. Mondelez's FCF payout ratio reached 107.8% on a trailing twelve-month basis, meaning the company returned $5.5B to shareholders while generating only $2.3B in free cash flow. The gap was funded by a 37-fold commercial paper surge to $2.6B. Management guided approximately $3B in FCF for 2026, which would cover the ~$2.5B annual dividend but leave limited room for buybacks without continued borrowing. The dividend itself ($1.79/share, ~3% yield) consumes roughly $2.3B annually — manageable if FCF recovers as guided, but vulnerable if cocoa costs remain elevated longer than expected.

How does Mondelez compare to Hershey on cocoa cost exposure?

Both companies suffered severe margin compression, but Hershey was hit harder: HSY's gross margin fell 1,380bps versus MDLZ's ~800bps decline. MDLZ's biscuit category (49% of revenue) has lower cocoa exposure than HSY's confectionery concentration. However, MDLZ's unique vulnerability is its capital structure response — a 37x commercial paper surge and greater than 100% FCF payout — which Hershey did not replicate. MDLZ's ROIC (7.29%) also trails HSY (10.84%) despite better relative margin performance, reflecting MDLZ's much larger intangible asset base ($43.9B in goodwill and intangibles, 61% of total assets).

What is supply chain financing and why does it matter for Mondelez?

Supply chain financing (SCF) is a bank-intermediated program where a financial institution pays Mondelez's suppliers early at a discount, and Mondelez repays the bank on its original terms. Mondelez has $3.6B in SCF obligations, representing 36% of its $10.0B accounts payable. This means the company's deeply negative working capital of -$8.4B is partially artificial. If SCF terms tighten due to rising rates, credit downgrades, or bank pullback, up to $3.6B could require alternative financing, swinging working capital from -$8.4B toward -$4.8B and reducing the perceived capital efficiency advantage by 43%.

What are the key risks to Mondelez's 2026 margin recovery?

Three risks threaten the guided recovery: (1) $1.1B in derivative hedging losses will flow through COGS over 6-18 months even if spot cocoa prices decline, because those derivatives hedge future purchases at peak prices; (2) the FY 2025 10-K escalates tariff risk, stating tariffs have "already increased costs for finished products, ingredients, and packaging" across 75.8% of non-US revenue; (3) volume was negative in all four regions, with North American pricing "essentially flat" due to category softness rather than pricing elasticity. Margin recovery requires genuine cost relief sufficient to offset both tariffs and deferred hedging losses.

Why did Mondelez's commercial paper borrowing increase so dramatically?

Short-term borrowings surged from $71M to $2,614M in nine months, a 37x increase, with commercial paper at a 4.4% weighted-average rate. The surge funded the gap between $2.3B in free cash flow and $5.5B in shareholder returns. The Board doubled long-term financing authorization from $2B to $4B at its December 2024 meeting — months before the worst margin compression was public — suggesting management had early internal visibility on the cash crunch. Average daily commercial paper outstanding was $2.2B for the first 9 months of 2025 versus $1.0B in the prior year, confirming this was structural, not seasonal.

What does Mondelez's ROIC of 7.3% mean for investors?

ROIC of 7.29% means Mondelez earns roughly 7 cents of after-tax operating profit per dollar of invested capital — the lowest in its peer group (HSY 10.84%, PEP 13.91%, MNST 25.66%, MO 32.63%) and approaching a reasonable WACC estimate of 7-9%. When ROIC falls below WACC, a company destroys shareholder value on an economic basis. MDLZ's ROIC is depressed by both the margin compression and its large intangible asset base ($43.9B in goodwill and intangibles, 61% of total assets), which inflates the invested capital denominator. Recovery above 10% requires adjusted operating income returning toward FY 2024's $5.9B level.

Is Mondelez's debt level concerning?

Total debt grew $4.0B to approximately $19.8B while operating income fell 44%. Interest coverage declined from 12.5x to 7.4x. Long-term debt fair value was $19.7B versus carrying value of $21.3B — trading at 92.3% of par, indicating the credit market is pricing in elevated risk. A $25B equity covenant provides only 4.7% headroom above the floor. While 7.4x interest coverage is still adequate for investment-grade credit, the trajectory — falling coverage, rising debt, commercial paper dependency — warrants monitoring. The $1.5B revolving credit facility maturing in 2026 adds near-term refinancing pressure.

How much of Mondelez's revenue comes from emerging markets?

Emerging markets contributed approximately 39.9% of FY 2025 revenue ($15.4B), growing at 8.5% versus 4.0% for developed markets. The growth premium carries specific risks: four countries (Argentina, Turkey, Egypt, Nigeria) totaling 2.8% of revenue operate under hyperinflationary accounting. Russia now represents 3.7% of revenue (~$1.4B) with "profitability above historic levels," creating binary expropriation risk if sanctions escalate. AMEA segment margin collapsed from 19.2% to 13.9% (9M, -530bps), showing that EM growth is not translating into profit growth. FX created $296M in unfavorable items for EM organic revenue during the first 9 months.

What is the Dual-Illusion EPS Framework?

A filing-derived analytical framework showing both GAAP EPS ($1.89) and management's Adjusted EPS ($2.92) are distorted in opposite directions. GAAP is understated by approximately $0.68/share from unrealized derivative marks — timing noise that inflates the apparent decline. Adjusted is overstated by approximately $0.42-$0.62/share because the excluded derivatives hedge future cocoa purchases whose losses will flow through COGS over 6-18 months. The filing-adjusted economic EPS of approximately $2.30-$2.50 retains only genuinely non-recurring items (pension settlements at $0.22/share) and recognizes approximately half of derivative losses as near-term COGS. This implies an effective P/E of 25-27x at ~$62/share — meaningfully higher than the ~21x the adjusted number suggests.

What is the ERP transformation and how does it affect earnings?

Mondelez is implementing a $1.2B enterprise resource planning system approved July 2024, with completion expected by year-end 2028. FY 2025 ERP costs totaled $163M in incremental operating expenses, approximately 3% of Adjusted Operating Income. ERP spending is accelerating — Q3 2025 costs were $41M versus $29M in Q3 2024. These costs are excluded from adjusted earnings and will continue for approximately 3 more years, after which efficiency gains across 150+ countries should create a margin tailwind that's currently invisible to investors focused on the cocoa narrative.

Methodology

Data Sources

This analysis draws from Mondelez International's FY 2025 10-K filed February 4, 2026, the Q3 2025 10-Q filed October 28, 2025, and MetricDuck's automated financial data pipeline covering 197+ calculated metrics. Peer data (HSY, PEP, MNST, MO) is sourced from their respective 10-K filings and MetricDuck pipeline metrics. All filing quotes are verbatim with section attribution. The filing-adjusted EPS framework is a derived analytical construct, not a company-reported metric.

Limitations

• Pipeline data lag: MetricDuck pipeline metrics for MDLZ reflect Q3 2025 TTM (through September 30, 2025), not full FY 2025. Where FY 2025 figures are available from the 10-K filing directly, those are used and tagged accordingly. Some metrics (FCF, OCF) remain TTM estimates pending full-year pipeline update.
• Hedge roll-off assumption: The filing-adjusted EPS estimate of ~$2.45 assumes approximately 50% of derivative losses are recognized through COGS within 12 months. Actual recognition depends on inventory turnover rates for cocoa-containing products and specific hedge contract durations, which Mondelez does not disclose. The filing states that hedging strategies "have not always protected and will not in the future always protect us."
• Cocoa hedge book undisclosed: The filing acknowledges hedging positions but does not disclose forward positions, durations, or strike prices, limiting the ability to model the exact COGS impact trajectory.
• Customer concentration undisclosed: No data on retailer dependency (Walmart, Costco, etc.) is available in the filing, limiting assessment of pricing power at the channel level.
• Tariff impact unquantified: The 10-K confirms tariffs have "already increased costs" but provides no dollar estimate, making the tariff headwind directional rather than precisely quantifiable.
• Peer comparison timing: MDLZ pipeline data is as of Q3 2025 while peer data extends to Q4 2025, creating a one-quarter lag in comparable metrics.

Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice. The author does not hold positions in MDLZ, HSY, PEP, MNST, or MO. Past performance and current metrics do not guarantee future results. All data is derived from public SEC filings and may contain errors or omissions from the automated extraction process. The filing-adjusted EPS framework involves assumptions about hedge roll-off rates that may not reflect actual outcomes.